Gene · 6103
RPGR: retinitis pigmentosa GTPase regulator
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RPGR: retinitis pigmentosa GTPase regulator. Genes, record 6103. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6103
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92834 | X-linked retinitis pigmentosa GTPase regulator | 1,020 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 61468 | Q92834 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 6633 | Q92834 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3776 | Q92834 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3776 | Q92834 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 6633 | Q92834 | Espacenet |
| US 12310997 B2 | 2025-05-27 | 113 | Q92834 | Espacenet |
| US 12246072 B2 | 2025-03-11 | 34 | Q92834 | Espacenet |
| KR 1020250023600 A | 2025-02-18 | 113 | Q92834 | Espacenet |
| EP 4491229 A2 | 2025-01-15 | 239 | Q92834 | Espacenet |
| WO 2024230934 A1 | 2024-11-14 | 364 | Q92834 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants858
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RPGR papers | Newest fiscal year |
|---|---|---|---|
| R01EY006855 | Models for Therapy of Hereditary Retinal Degeneration | 30 | 2025 |
| R01EY018213 | Defining Barriers to Gene Therapy | 25 | 2025 |
| P30EY001583 | P30 Core Grant For Vision Research | 23 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 22 | 2025 |
| R01EY024698 | Gene Editing and Silencing in Phototransduction | 17 | 2025 |
| P30EY014104 | P30 Core Grant for Vision Research | 15 | 2025 |
| R01EY012910 | Precision Medicine for Inherited Retinal Degenerations | 12 | 2025 |
| R01EY022356 | Molecular Basis of Human Visual System Disorders | 12 | 2025 |
| R01EY018571 | Genetics of early onset retinal diseases | 11 | 2025 |
| R01EY017607 | Assessing Photoreceptor Structure and Function in Normal and Diseased Retinae | 10 | 2025 |
1 to 10 of 858Source NIH's project files
See all 858 nih grantsPapers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tapetal-like reflex in RPGR-associated retinal dystrophies: two cases with distinct phenotypes. | Doc Ophthalmol | 2026 | 42758434 | PubTator, text mining | PubMed |
| IMU-based identification of rowing conditions through supervised machine learning. | BMC Sports Sci Med Rehabil | 2026 | 42745342 | PubTator, text mining | PubMed |
| Progress in gene therapy for RPGR-associated X-linked retinitis pigmentosa. | Expert Opin Biol Ther | 2026 | 42733973 | PubTator, text mining | PubMed |
| Functional Outcomes and Ocular Safety of Subretinal AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: A Systematic Review and Meta-Analysis. | J Clin Med | 2026 | 42652548 | PubTator, text mining | PubMed |
| Genetic Insights Into Retinitis Pigmentosa: A De Novo RPGR Mutation in an Iranian-Azeri Family. | Case Rep Ophthalmol Med | 2026 | 42609816 | PubTator, text mining | PubMed |
| Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis. | J Transl Med | 2026 | 42576225 | PubTator, text mining | PubMed |
| Defining a Novel RPGR Phenotype of Sector Retinitis Pigmentosa With Cone Dystrophy. | Invest Ophthalmol Vis Sci | 2026 | 42573183 | PubTator, text mining | PubMed |
| PAX6-associated aniridia and RPGR-related X-linked retinitis pigmentosa: a rare dual Mendelian molecular diagnosis. | BMJ Case Rep | 2026 | 42538049 | PubTator, text mining | PubMed |
| Clinical and Genetic Landscape of RPGR -Associated Retinal Dystrophies in Portugal: Insights From the Nationwide IRD-PT Registry. | Clin Exp Ophthalmol | 2026 | 42521440 | PubTator, text mining | PubMed |
| A novel chimeric RNA RPGR-EEF1A1 enhances autophagy by interaction with the small GTPase RAB37 in a GTP-dependent manner. | Genes Dis | 2026 | 42389718 | PubTator, text mining | PubMed |
1 to 10 of 1,847
See all 1,847 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6103
GET https://conductscience.org/api/genes/v1/6103/patents?page=2